DXCM
DexCom Inc.
Latest News for DXCM
Barclays analyst Matt Miksic maintained a Sell rating on Dexcom on May 15 and set a price target of $64.00. The company’s shares closed last Friday......
Traders seeking the hottest stock market stories for Friday will find them in our daily wrap-up. ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Galectin Therapeutics (GALT) and......
Dexcom ($DXCM) stock jumped about 8% on Friday, at the time of writing, as activist investor Elliott Investment Management took a stake in the make......
RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Dexcom today and set a price target of $85.00. According to TipRanks, Singh Chad......
BTIG analyst Marie Thibault reiterated a Buy rating on Dexcom today and set a price target of $80.00. Thibault covers the Healthcare sector, focusi......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Bristol-Myers Squibb (BMY) with bu......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biogen (BIIB), RegenXBio (RGNX) and Dexcom (DXCM) wi......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Tonix Pharma (TNXP) with bullish s......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG ......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 20 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DXCM | $72.01 | -0.1% | 5.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |